Wen Luo is the founder of Denovo Biopharma. Denovo Biopharma has raised $172M in total funding. Latest round: Series D. Backed by Yingke Capital.
Dr. Wen Luo is the founder, Chair, and CEO of Denovo Biopharma, a clinical-stage biopharmaceutical company based in San Diego. The company focuses on biomarker-driven precision medicines, and he leads the development of their precision medicine strategies.
Full founder directory · Investor directory · Company funding database · Fundraising library